The aims of the current study were to extend the analysis of FGD3 gene expression by IHC to a series of breast cancer patients at all age treated at our institution and to compare the effectiveness of FGD3 expression to that of traditional prognostic factors. This evidence concerns the gene FGD3 and breast cancer.